Results 21 to 30 of about 9,651,090 (393)

Evaluation of adherence to calcium, vitamin D and drugs for osteoporosis in patients with low bone mineral density [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2017
Introduction/Objective. Osteoporosis is a systemic disease of bone tissue, which leads to an increase in bone fragility and higher risk of fractures. The aim of the study was to determine adherence to calcium, vitamin D, and drugs for osteoporosis in ...
Maksimović Marina, Jurišić Vladimir, Erdeljan Biljana, Zvekić-Svorcan Jelena, Lazarević Biljana, Dojčinović Dragana   +5 more
doaj   +1 more source

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study

RMD Open, 2023
Objective Gout is associated with lifestyle, body mass index (BMI) and comorbidities, including dyslipidaemia. We studied how in actively treated patients, anthropometric measures and lipid levels changed over 2 years and whether they predicted gout ...
Tore K Kvien, Joseph Sexton, Till Uhlig, Espen A Haavardsholm, Hilde Berner Hammer, Lars Fridtjof Karoliussen   +5 more
doaj   +1 more source

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis

BMC Rheumatology, 2020
Background The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value.
Katie Bechman, Anthony Dalrymple, Charles Southey-Bassols, Andrew P. Cope, James B. Galloway   +4 more
doaj   +1 more source

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

BMC Musculoskeletal Disorders, 2021
Background The purpose of this study was to determine the prevalence of high disease activity as measured using the Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients who nonetheless have low Bath Ankylosing ...
Bora Nam, Bon San Koo, Tae-Han Lee, Ji-Hui Shin, Jin-Ju Kim, Seunghun Lee, Kyung Bin Joo, Tae-Hwan Kim   +7 more
doaj   +1 more source

American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

Arthritis & Rheumatology, 2022
To provide guidance to rheumatology providers on the use of COVID‐19 vaccines for patients with rheumatic and musculoskeletal diseases (RMDs).
J. Curtis, S. Johnson, Dona Anthony, R. Arasaratnam, L. Baden, A. Bass, C. Calabrese, E. Gravallese, R. Harpaz, Andrew T. Kroger, R. Sadun, Amy S. Turner, E. Williams, T. Mikuls   +13 more
semanticscholar   +1 more source

Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study

BMC Health Services Research, 2023
Background Remote care has the potential of improving access to timely care for people with inflammatory joint diseases (IJD), but there is limited knowledge on how this approach is regarded by healthcare professionals (HCP).
Emil Eirik Kvernberg Thomassen, Inger Jorid Berg, Eirik Klami Kristianslund, Anne Therese Tveter, Nina Østerås   +4 more
doaj   +1 more source

Histopathology of the gut in rheumatic diseases [PDF]

, 2018
The gastrointestinal tract regulates the trafficking of macromolecules between the environment and the host through an epithelial barrier mechanism and is an important part of the immune system controlling the equilibrium between tolerance and immunity ...
Ciccia F., Ferrante A., Guggino G., Macaluso F., Rizzo A.   +4 more
core   +1 more source

2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases

Annals of the Rheumatic Diseases, 2022
Background Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring.
A. de Thurah, P. Bosch, A. Marques, Y. Meissner, C. Mukhtyar, J. Knitza, A. Najm, N. Østerås, T. Pelle, L. Knudsen, H. Šmucrová, F. Berenbaum, M. Jani, R. Geenen, M. Krusche, P. Pchelnikova, Savia de Souza, S. Badreh, D. Wiek, S. Piantoni, J. Gwinnutt, C. Duftner, H. Canhão, L. Quartuccio, N. Stoilov, Yeliz Prior, J. Bijlsma, A. Zabotti, T. Stamm, C. Dejaco   +29 more
semanticscholar   +1 more source

SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis

Arthritis & Rheumatology, 2021
The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among people with rheumatic and musculoskeletal diseases (RMDs) compared to those without RMDs is unclear.
R. Conway, A. Grimshaw, M. Konig, M. Putman, A. Duarte-García, L. Tseng, Diego M. Cabrera, Yu Pei Chock, H. Degirmenci, Eimear Duff, B. Egeli, Elizabeth R Graef, Akash Gupta, P. Harkins, B. Hoyer, A. Jayatilleke, S. Jin, Christopher Kasia, Aneka Khilnani, Adam Kilian, A. Kim, C. M. Lin, C. Low, L. Proulx, S. Sattui, Namrata Singh, J. Sparks, H. Tam, M. Ugarte-Gil, Natasha Ung, Kaicheng Wang, Leanna M. Wise, Ziyi Yang, Kristen J Young, J. Liew, R. Grainger, Z. Wallace, E. Hsieh   +37 more
semanticscholar   +1 more source

Long term effectiveness of RA-1 as a monotherapy and in combination with disease modifying anti-rheumatic drugs in the treatment of rheumatoid arthritis

Journal of Ayurveda and Integrative Medicine, 2018
Background: Data on long term use of Ayurvedic drugs is sparse. They may prove useful if combined with modern medicine in certain clinical situations (integrative medicine).
Arvind Chopra, Manjit Saluja, Toktam Kianifard, Deepa Chitre, Anuradha Venugopalan   +4 more
doaj   +1 more source